Successes and challenges of using whole exome sequencing to identify novel genes underlying an inherited predisposition for thoracic aortic aneurysms and acute aortic dissections

Trends Cardiovasc Med. 2014 Feb;24(2):53-60. doi: 10.1016/j.tcm.2013.06.004. Epub 2013 Aug 15.

Abstract

Thoracic aortic aneurysms involving the aortic root and/or ascending aorta can lead to acute aortic dissections. Approximately 20% of patients with thoracic aortic aneurysms and dissections (TAAD) have a family history of the disease, referred to as familial TAAD (FTAAD) that can be inherited in an autosomal dominant manner with variable expression with respect to disease presentation, age of onset and associated features. Whole exome sequencing (WES) has been used to identify causative mutations in novel genes for TAAD. The strategy used to reduce the large number of rare variants identified using WES is to sequence distant relatives with TAAD and filter for heterozygous rare variants that are shared between the relatives, predicted to disrupt protein function and segregate with the TAAD phenotype in other family members. Putative genes are validated by identifying additional families with a causative mutation in the genes. This approach has successfully identified novel genes for FTAAD.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Disease
  • Aortic Aneurysm, Thoracic / genetics*
  • Aortic Aneurysm, Thoracic / metabolism
  • Aortic Aneurysm, Thoracic / mortality
  • Aortic Dissection / genetics*
  • Aortic Dissection / metabolism
  • Aortic Dissection / mortality
  • DNA Mutational Analysis
  • Exome*
  • Gene Regulatory Networks
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genetic Testing / methods*
  • Genetic Variation
  • Genome, Human*
  • Heredity
  • Humans
  • Mutation
  • Pedigree
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Sequence Analysis, DNA*